Table of Contents, The Alkaloids vol 56, Academic Press - Ibogaine Proceedings
The Ibogaine Dossier
The Ibogaine Dossier

NYU Conference on Ibogaine Nov 5-6, 1999





Search the Ibogaine Dossier

(enter search term) Google

iboga fruit
variety iboga fruit
















iboga roots
T. iboga roots

















spiritual entity
Spiritual Entity
Mitsogo Bwiti
Photo by Gollnhofer

















Self-Help graphic
Graphic
Art Buro, Amsterdam
Squatter Movement

Prepared for ICASH
International Coalition
for Addict Self-Help

Main | Search | Science | Opinion | Literature | Links | Treatment | Bookshop | Feedback
The Ibogaine Dossier

The Alkaloids

Volume 56

Edited by Kenneth R. Alper and Stanley D. Glick

Academic Press © 2001

This book available from Academic Press
This book available from Amazon.com
Read Chapter 14: html version
INDEX Now available.

The book Index and chapters are now available as PDF files linked to the Table of Contents.

TABLE of CONTENTS


 

CONTRIBUTORS

FOREWORD BY HERB KLEBER

PREFACE BY GEOFFREY A. CORDELL

PREFACE BY KENNETH R. ALPER AND STANLEY D. GLICK

NUMBERING OF IBOGA ALKALOIDS

 

   ix

  xv

 xix

 xxi

xxiii

 

Ibogaine: A Review

KENNETH R. ALPER

I.

II.

III.

IV.

V.

VI.

VII.

VIII.

IX.

X.

 

Introduction, Chemical Properties and Historical Time Line.

Mechanisms of Action

Evidence of Efficacy in Animal Model

Evidence of Efficacy and Subjective Effects in Humans

Pharmacokinetics

Safety

Learning, Memory and Neurophysiology

Anthropological and Sociological Perspectives

Economic and Political Perspectives

Conclusions

References

 2

 6

 12

 16

 19

 22

 27

 30

 31

 32

 33

 

Mechanisms of Action of Ibogaine: Relevance to Putative Therapeutic Effects and Development of a Safer Iboga Alkaloid Congener

STANLEY D. GLICK, ISABELLE M. MAISONNEUVE AND KAREN K. SZUMLINSKI

 

I.

II.

III.

IV.

V.

VI.

VII.

VIII.

 

 

Introduction

Behavioral and Neurochemical Methods

Opioid Interactions

Stimulant Interactions

Metabolism and Distribution of Ibogaine and 18-MC

Toxicity

Mechanisms

Discussion

References

 

 39

 41

 42

 45

 48

 48

 49

 50

 52

 

Ibogaine as a Glutamate Antagonist: Relevance to Putative Antiaddictive Properties

PHIL SKOLNICK

 

I.

II.

III.

 

Overview

NMDA Antagonist Properties of Ibogaine

Are the NMDA Antagonist Properties of Ibogaine Relevant to its Putative Antiaddictive Properties?

References

 55

 56

 58

 61

 

Drug Discrimination Studies with Ibogaine

SCOTT HELSLEY, RICHARD A. RABIN AND J.C. WINTER

 

I.

II.

III.

 

Introduction

Ibogaine in Drug Discrimination Studies

Summary

References

 63

 65

 75

 76

 

Comparative Neuropharmacology of Ibogaine and Its O-Desmethyl Metabolite, Noribogaine

MICHAEL H. BAUMANN, JOHN PABLO, SYED F. ALI, RICHARD B. ROTHMAN AND DEBORAH C. MASH

 

I.

II.

III.

IV.

V.

VI.

 

Introduction

Pharmacokinetics

Neurochemical Mechanisms

Neuroendocrine Effects

Adverse Consequences

Conclusions

References

 80

 82

 85

100

103

107

109

 

Characterization of Multiple Sites of Action of Ibogaine

HENRY SERSHEN, AUDREY HASHIM AND ABEL LAJTHA

 

I.

II.

III.

IV.

V.

VI.

VII.

VIII.

 

Introduction

Issues Related to Ibogaine in the Treatment of Drug Dependence

Effects of Ibogaine on Drug-Induced Behavior

Binding Site Activity

Functional Activity

Stimulant Drug Actions/Behaviors

Current Non-Ibogaine Drug Treatment Protocols

Conclusions

References

115

117

119

119

122

124

127

129

130

 

Changes in Gene Expression and Signal Transduction Following Ibogaine Treatment

SAMUEL S. ONAIVI, B. EMMANUEL AKINSHOLA, SYED F. ALI

 

I.

II.

III.

IV.

V.

 

Introduction

In Vitro Action of Cocaine on Ca2+ and Protein Kinase C Signaling

Effects of Ibogaine on the Action of Cocaine in Vivo

Expression of Genes Regulated by Ibogaine Using cDNA Micro Analysis

Conclusions

References

136

142

146

149

151

152

 

Ibogaine in the Treatment of Heroin Withdrawal

DEBORAH C. MASH, CRAIG A. KOVERA, JOHN PABLO, RACHEL TYNDALE, FRANK R. ERVIN, JEFFREY D. KAMLET AND W. LEE HEARN

 

I.

II.

III.

IV.

V.

VI.

VII.

VIII.

IX.

X.

XI.

 

Introduction

Identification of a Primary Metabolite of Ibogaine

Cytochrome P450 Metabolism and Genetic Polymorphisms

Ibogaine Pharmacokinetics

Setting and Study Design

Physician Ratings of Withdrawal

Subject's Self-Report of Withdrawal Symptoms

Acute Detoxification and Behavioral Outcomes

Cardiovascular Changes and Side Effects of Ibogaine

Mechanism of Action

Conclusion and Future Directions

References

156

157

158

160

161

162

163

163

165

167

169

170

 

Sigma Receptors and Iboga Alkaloids

WAYNE D. BOWEN

 

I.

II.

III.

IV.

V.

VI.

 

Introduction

Sigma Receptors

Binding of Iboga Alkaloids to Sigma Receptors

Effect of Iboga Alkaloids on Intracellular Cystolic Calcium

Effect of Iboga Alkaloids on Cellular Morphology and Induction of Apoptosis

Summary and Discussion

References

173

174

178

180

181

184

188

 

Ibogaine Neurotoxicity Assessment: Electrophysiological, Neurochemical, and Neurohistological Methods

ZBIGINEW K. BINIENDA, ANDREW C. SCALLET, LARRY C. SCHMUED, AND
SYED F. ALI

 

I.

II.

III.

IV.

 

Introduction

Electroencephalography and Ibogaine

Other Studies of Ibogaine Neurotoxicity at FDA/NCTR

Conclusions

References

193

194

200

209

209

 

Modulation of the Effects of Rewarding Drugs by Ibogaine

LINDA A. PARKER AND SHEPARD SIEGEL

 

I.

II.

III.

IV.

V.

VI.

 

Introduction

Ibogaine-Morphine Interactions

Ibogaine and Morphine Reward

Ibogaine and Other Drugs of Abuse

Ibogaine and Cravin: Future Directions

Conclusions

References

212

212

213

219

220

222

223

 

Anxiogenic Action of Ibogaine

PIOTR POPIK AND MALGORZATA WROBEL

 

I.

II.

III.

 

Introduction

Ibogaine and Anxiety

Discussion

References

227

229

231

232

 

"Returning to the Path": The use of Iboga[ine] in Equatorial African Ritual Context and the Binding of Time, Space, and Social Relationships

JAMES W. FERNANDEZ AND RENATE L. FERNANDEZ

 


I.

II.

III.

IV.


V.

VI.

 


Introduction

Time Binding in Professional and Religious Worlds

Pathologies of the Colonial World and the Role of Iboga in Religious Movements

A Comparison of the Introduction and Maintenance of Iboga Use in Bwiti and in Therapeutic Settings (INTASH)

The Contemporary of Ethnography of Iboga Use

Conclusions

References


235

236

237

239


243

247

247

 

A Contemporary History of Ibogaine in the United States and Europe

KENNETH R. ALPER, DANA BEAL AND CHARLES D. KAPLAN

 

I.

II.

III.

IV.

 

Introduction

Ibogaine Treatment Scenes: History and Description

The Political Subculture of Advocacy

Conclusions

References

250

250

267

277

279

 

From the Roots Up: Ibogaine and Addict Self-Help

GEERTE FRENKEN

 

I.

II.

III.

IV.

V.

 

Introduction of Ibogaine and Addict Self-Help in the Netherlands

Intake and Treatment

Psychological Aspects of the Ibogaine Treatment Experience

Aftercare

Conclusions

References

283

285

287

289

290

292

 

Case Studies of Ibogaine Treatment: Implications for Patient Management Strategies

HOWARD S. LOTSOF AND NORMA E. ALEXANDER

 

I.

II.

III.

IV.

V.

VI.

 

Introduction

Drug-User Group

Self-Help Organizations

Regulatory Development and Clinical Research Settings

Psychological Aftereffects

Discussion

References

293

294

298

302

306

309

312

 

CUMULATIVE INDEX OF TITLES

INDEX

 

315

325




Available from Academic Press

Available from Amazon.com

Read Chapter 14: complete text



Top of page | Main | Search | Science | Opinion | Literature | Links | Treatment | Bookshop | Feedback

Tabernanthe iboga © 1999
The Ibogaine Dossier